AT358556B - Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen - Google Patents

Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen

Info

Publication number
AT358556B
AT358556B AT839978A AT839978A AT358556B AT 358556 B AT358556 B AT 358556B AT 839978 A AT839978 A AT 839978A AT 839978 A AT839978 A AT 839978A AT 358556 B AT358556 B AT 358556B
Authority
AT
Austria
Prior art keywords
aralkylsul
finyl
salts
producing new
acetohydroxamic acids
Prior art date
Application number
AT839978A
Other languages
English (en)
Other versions
ATA839978A (de
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of ATA839978A publication Critical patent/ATA839978A/de
Application granted granted Critical
Publication of AT358556B publication Critical patent/AT358556B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/72—Acyl halides containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT839978A 1976-03-23 1978-11-24 Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen AT358556B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11710/76A GB1574822A (en) 1976-03-23 1976-03-23 Acetohydroxamic acid derivatives and pharmaceutical compositions thereof
GB629877 1977-02-15

Publications (2)

Publication Number Publication Date
ATA839978A ATA839978A (de) 1980-02-15
AT358556B true AT358556B (de) 1980-09-25

Family

ID=26240593

Family Applications (5)

Application Number Title Priority Date Filing Date
AT193077A AT356078B (de) 1976-03-23 1977-03-21 Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze
AT839878A AT361932B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung von neuen piperazin-1 -yl-acethydroxamsaeuren und deren salzen
AT839978A AT358556B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen
AT0840078A AT362793B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer ureido-acetohydroxamsaeuren und deren metallsalzen
AT0501480A AT374191B (de) 1976-03-23 1980-10-09 Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT193077A AT356078B (de) 1976-03-23 1977-03-21 Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze
AT839878A AT361932B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung von neuen piperazin-1 -yl-acethydroxamsaeuren und deren salzen

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT0840078A AT362793B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer ureido-acetohydroxamsaeuren und deren metallsalzen
AT0501480A AT374191B (de) 1976-03-23 1980-10-09 Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen

Country Status (25)

Country Link
US (7) US4122186A (de)
JP (1) JPS52144601A (de)
AT (5) AT356078B (de)
AU (1) AU516473B2 (de)
BE (1) BE852738A (de)
CA (2) CA1120928A (de)
CH (1) CH620894A5 (de)
CS (1) CS200511B2 (de)
DD (1) DD129645A5 (de)
DE (1) DE2711451A1 (de)
DK (1) DK171197B1 (de)
ES (1) ES457105A1 (de)
FI (1) FI62821C (de)
FR (4) FR2345430A1 (de)
GB (1) GB1574822A (de)
IE (1) IE44721B1 (de)
IL (1) IL51705A (de)
LU (1) LU76989A1 (de)
NL (1) NL188801C (de)
NO (4) NO144420C (de)
NZ (1) NZ183616A (de)
PH (1) PH16271A (de)
PT (1) PT66300B (de)
SE (4) SE432420B (de)
SU (1) SU689617A3 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
US4405357A (en) 1980-06-02 1983-09-20 Fmc Corporation Herbicidal 3-isoxazolidinones and hydroxamic acids
FR2502617B1 (de) * 1981-03-25 1984-04-27 Lafon Labor
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
JPS59222454A (ja) * 1983-05-31 1984-12-14 Ajinomoto Co Inc アミノ酸の製造方法
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
FR2584666B1 (fr) * 1985-07-10 1989-06-16 Champion Spark Plug Europ Bras moteur pour balai d'essuie-glace avec capuchon coulissant
FR2585699B1 (fr) * 1985-07-31 1988-03-11 Lafon Labor Derive d'acide acetohydroxamique, procede de preparation et utilisation en therapeutique
US5036157A (en) * 1986-03-11 1991-07-30 Burroughs Wellcome Co. Aryl derivatives
FR2601673B2 (fr) * 1986-07-21 1989-06-02 Lafon Labor Derives de l'acetamide et medicaments qui en contiennent
US4983567A (en) * 1987-03-16 1991-01-08 Biomeasure, Inc. Immunomodulators and methods of making same
ES2011588A6 (es) * 1989-05-29 1990-01-16 Vinas Lab Procedimiento para la preparacion de un nuevo derivado fenilacetico.
JPH0359402U (de) * 1989-10-13 1991-06-12
CA2028530A1 (en) * 1989-11-21 1991-05-22 Christian Hubschwerlen Substituted pyrimidobenzimidazole derivatives
US5283248A (en) * 1989-11-21 1994-02-01 Hoffmann-La Roche Inc. Amino substituted pyrimido[1,6-2]benzimidazoles
US5378701A (en) * 1991-12-27 1995-01-03 Kyowa Hakko Kogyo Tricyclic compounds
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
JP2001513771A (ja) * 1997-02-27 2001-09-04 アメリカン・サイアナミド・カンパニー マトリクス金属プロテイナーゼ阻害薬としてのｎ−ヒドロキシ−２−（アルキル、アリール、またはヘテロアリールスルファニル、スルフィニルまたはスルホニル）−３−置換アルキル、アリールまたはヘテロアリールアミド
US6187924B1 (en) * 1997-11-12 2001-02-13 Darwin Discovery, Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
PE20001566A1 (es) 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6686502B1 (en) 1999-03-26 2004-02-03 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
GB9911071D0 (en) * 1999-05-12 1999-07-14 Darwin Discovery Ltd Hydroxamic and carboxylic acid derivatives
EP1461308B1 (de) * 2001-12-04 2006-12-20 De Novo Pharmaceuticals Ltd. Bakterielle enzyminhibitoren
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
US7842835B2 (en) * 2003-07-07 2010-11-30 Georgetown University Histone deacetylase inhibitors and methods of use thereof
EP1644323B1 (de) * 2003-07-07 2015-03-18 Georgetown University Histondeacetylaseinhibitoren und verfahren zu deren anwendung
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
WO2007134169A2 (en) * 2006-05-10 2007-11-22 Nuada, Llc Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
US20090264384A1 (en) * 2004-11-01 2009-10-22 Nuada, Inc. Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
WO2007113644A2 (en) * 2006-04-05 2007-10-11 Orchid Research Laboratories Limited New hdac inhibitors
ES2452822T3 (es) 2006-06-28 2014-04-02 Amgen Inc. Inhibidores del transportador 1 de glicina
CA2663569A1 (en) * 2006-09-28 2008-04-03 Merck & Co., Inc. Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
CA2667826C (en) * 2006-10-28 2013-10-08 Methylgene Inc. Inhibitors of histone deacetylase
WO2008094592A1 (en) * 2007-02-01 2008-08-07 Panthera Biopharna, Llc Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
FR2957492B1 (fr) 2010-03-18 2013-08-16 Rhodia Operations Nouvelles utilisations de composes de type esteramide
CN101982459A (zh) * 2010-10-21 2011-03-02 山东华尔康生物技术有限公司 乙酰氧肟酸的制备工艺
GB201509663D0 (en) * 2015-06-03 2015-07-15 Johnson Matthey Plc Benzo(h)quinoline ligands and complexes thereof
US11993575B1 (en) 2023-12-29 2024-05-28 King Faisal University Ethyl [4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]acetate as an antimicrobial compound
US11970462B1 (en) 2024-01-03 2024-04-30 King Faisal University Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862020A (en) * 1958-11-25 Derivatives of a-amino-p-hydroxy
US2279560A (en) * 1940-05-08 1942-04-14 Du Pont Viscous hydrocarbon oil
US2397508A (en) * 1943-05-29 1946-04-02 Standard Oil Co Hydroxamic acids
GB894119A (en) * 1959-11-02 1962-04-18 Ici Ltd Pivalic acid derivative
US3275643A (en) * 1963-07-19 1966-09-27 Irwin I Lubowe Allantoin-pantothenate compounds
US3634509A (en) * 1966-06-08 1972-01-11 Shell Oil Co 2 6-dinitroanilinoacetamides
NL6715600A (de) * 1966-12-02 1968-06-04
US3927092A (en) * 1968-06-24 1975-12-16 Merck & Co Inc Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1805548A1 (de) * 1968-10-26 1970-10-08 Agfa Gevaert Ag Benzimidazol-Derivate und ihre photographische Verwendung
FR2036953A1 (en) * 1969-04-23 1970-12-31 Pluripharm Diphenylhydantoin derivs
US4092430A (en) * 1970-09-09 1978-05-30 Ciba-Geigy Corporation Antiphlogistic phenylacetohydroxamic acid compositions
US3728380A (en) * 1971-05-17 1973-04-17 Morton Norwich Products Inc P-chlorobenzamidoacetohydroxamic acid
US3839580A (en) * 1972-08-14 1974-10-01 Morton Norwich Products Inc 2-p-(nitrobenzamido)acetohydroxamic for treating urinary tract infections
SE7411007L (de) * 1973-10-10 1975-04-11 Ciba Geigy Ag
JPS51102636A (en) * 1974-04-03 1976-09-10 Fuji Photo Film Co Ltd Karaashashingazo no keiseihoho
FR2285859A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Phenylsulfinyl-amidines et derives
CH593954A5 (de) * 1975-07-21 1977-12-30 Ciba Geigy Ag
US4029812A (en) * 1976-02-18 1977-06-14 The Dow Chemical Company Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides

Also Published As

Publication number Publication date
CA1130301A (en) 1982-08-24
NO152972B (no) 1985-09-16
FR2453133A1 (fr) 1980-10-31
ES457105A1 (es) 1978-10-16
DK126677A (da) 1977-09-24
SE458605B (sv) 1989-04-17
PT66300B (pt) 1978-08-10
NO144420B (no) 1981-05-18
FI62821B (fi) 1982-11-30
DK171197B1 (da) 1996-07-22
FR2345430A1 (fr) 1977-10-21
DE2711451A1 (de) 1977-10-06
AT356078B (de) 1980-04-10
IE44721L (en) 1977-09-23
FR2453148B1 (de) 1983-12-02
DD129645A5 (de) 1978-02-01
NO803337L (no) 1977-09-26
SE8302172D0 (sv) 1983-04-19
JPS628424B2 (de) 1987-02-23
US4225617A (en) 1980-09-30
NO144420C (no) 1981-08-26
US4151300A (en) 1979-04-24
PH16271A (en) 1983-08-25
NO803338L (no) 1977-09-26
NO146431C (no) 1982-09-29
ATA839878A (de) 1980-09-15
SE8302172L (sv) 1983-04-19
CA1120928A (en) 1982-03-30
SE456992B (sv) 1988-11-21
SE8302173D0 (sv) 1983-04-19
DE2711451C2 (de) 1990-05-10
AU2334477A (en) 1978-09-21
IL51705A0 (en) 1977-05-31
NO771006L (no) 1977-09-26
ATA840078A (de) 1980-11-15
US4152458A (en) 1979-05-01
FR2453148A1 (fr) 1980-10-31
FR2453158B1 (de) 1982-08-06
SE432420B (sv) 1984-04-02
CS200511B2 (en) 1980-09-15
NL188801C (nl) 1992-10-01
US4183951A (en) 1980-01-15
SE8302173L (sv) 1983-04-19
PT66300A (fr) 1977-04-01
BE852738A (fr) 1977-09-22
ATA193077A (de) 1979-09-15
AT362793B (de) 1981-06-10
IE44721B1 (en) 1982-03-10
SU689617A3 (ru) 1979-09-30
NO146431B (no) 1982-06-21
ATA501480A (de) 1983-08-15
CH620894A5 (de) 1980-12-31
AT374191B (de) 1984-03-26
SE8302171D0 (sv) 1983-04-19
JPS52144601A (en) 1977-12-02
NO803336L (no) 1977-09-26
NO145881C (no) 1982-06-16
FR2453133B1 (de) 1984-04-06
NL7703168A (nl) 1977-09-27
SE7703263L (sv) 1977-09-24
FR2453158A1 (fr) 1980-10-31
ATA839978A (de) 1980-02-15
US4209524A (en) 1980-06-24
FR2345430B1 (de) 1982-07-23
AT361932B (de) 1981-04-10
NO152972C (no) 1985-12-27
US4209523A (en) 1980-06-24
SE8302171L (sv) 1983-04-19
GB1574822A (en) 1980-09-10
FI770859A (de) 1977-09-24
AU516473B2 (en) 1981-06-04
NZ183616A (en) 1979-03-28
LU76989A1 (de) 1977-07-18
IL51705A (en) 1982-09-30
SE452155B (sv) 1987-11-16
FI62821C (fi) 1983-03-10
US4122186A (en) 1978-10-24
NO145881B (no) 1982-03-08

Similar Documents

Publication Publication Date Title
AT358556B (de) Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen
AT352736B (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT377254B (de) Verfahren zur herstellung neuer substituierter pyrrolidine und deren salzen
AT372946B (de) Verfahren zur herstellung neuer bis-aminopyridine und deren salze
AT350737B (de) Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen
ATA54480A (de) Verfahren zur herstellung neuer benzopyranderivate und deren salze
AT360513B (de) Verfahren zur herstellung neuer dimerer indol- -dihydroindol-carboxamide und ihrer salze
ATA246077A (de) Verfahren zur herstellung neuer polyjodierter sisophthalsaeureamide und deren salzen
ATA622077A (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
AT355014B (de) Verfahren zur herstellung neuer 2-benzopyranon- derivate und ihrer salze
ATA342176A (de) Verfahren zur herstellung neuer 2-imidazolyl- chinazoline und ihrer salze
ATA265579A (de) Verfahren zur herstellung neuer substituierter aethanolamine und deren salzen
AT350058B (de) Verfahren zur herstellung neuer phthalazinon- und chinazolinonaralkylamine und deren salzen
ATA407977A (de) Verfahren zur herstellung neuer hydrazinopyridazinderivate und deren salzen
AT369738B (de) Verfahren zur herstellung neuer thiodibenzoxepine und deren saeureadditionssalze
AT374800B (de) Verfahren zur herstellung neuer guanidinothiazole und von deren salzen
AT358196B (de) Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen
DD107898A5 (de) Verfahren zur herstellung neuer 3-und 2-butensaeure-derivate
AT374178B (de) Verfahren zur herstellung neuer indolderivate und deren salzen
ATA42580A (de) Verfahren zur herstellung neuer chinazolonderivateund ihrer salze
ATA338079A (de) Verfahren zur herstellung neuer 1-amino-2- -hydroxy-3-heterocyclyloxy-progane und ihrer salze
ATA8479A (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT355582B (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
AT362348B (de) Verfahren zur herstellung neuer naphthylamin- derivate und ihrer saeureadditionssalze
ATA393679A (de) Verfahren zur herstellung neuer 1-(2-phenyl-2-hydroxyaethylamino)-3-phenoxy-propan-2-olen und derensaeureadditionssalzen

Legal Events

Date Code Title Description
ELA Expired due to lapse of time